RESUMEN
Hemosuccus pancreaticus is defined as upper gastrointestinal hemorrhage from the ampulla of Vater via the pancreatic duct. It is a rare disease, with non-specific presentation, challenging to diagnose and difficult to treat, with high mortality rates in untreated patients with massive bleeding. Given the intermittent nature of the bleeding, delays in diagnosis frequently occur. Timely diagnosis and treatment seem to result in markedly reduced mortality, therefore we emphasize the diagnostic contribution of imaging techniques by presenting the case of a patient with chronic pancreatitis in whom computed tomography established the diagnosis of blood in the Wirsung duct and contrast-enhanced ultrasound brought its added value by excluding the active bleeding.
Asunto(s)
Hemorragia Gastrointestinal/diagnóstico por imagen , Pancreatitis Crónica/diagnóstico por imagen , Fosfolípidos , Hexafluoruro de Azufre , Tomografía Computarizada por Rayos X/métodos , Ultrasonografía/métodos , Medios de Contraste , Diagnóstico Diferencial , Hemorragia Gastrointestinal/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Conductos Pancreáticos/diagnóstico por imagen , Pancreatitis Crónica/complicacionesRESUMEN
BACKGROUND AND AIMS: There is little awareness and a lack of data on the prevalence of hospital malnutrition in gastro-enterology departments. Since part of these patients are referred for surgical treatment and poor nutritional status is a known risk factor for perioperative morbidity, we conducted a prospective study aimed to screen for the nutritional risk and assess the prevalence and risk factors of malnutrition in gastro-enterology departments in Romania. METHODS: We included patients consecutively admitted to 8 gastroenterology units over a period of three months in our study. Nutritional risk was evaluated using NRS 2002. Malnutrition was defined using BMI ( 20 kg m2) or and 10% weight loss in the last six months. RESULTS: 3198 patients were evaluated, 51.6% males and 48.4% females, with the mean age of 54.5 Â+- 14.3 years. Overall percentage of patients at nutritional risk was 17.1%, with the highest risk for patients with advanced liver diseases (49.8%), oncologic (31.3%), inflammatory bowel diseases (20.2%), and pancreatic diseases (18.9%). The overall prevalence of malnutrition was of 20.4%, higher for advanced liver diseases (39.4%), inflammatory bowed diseases (30.6%), oncologic (26.8%) and pancreatic diseases (23%). Independent risk factors for malnutrition were younger age (p 0.0001), female gender (p 0.0001), a higher (A ≥ 3) NRS (p 0.0001), presence of neoplasm (p 0.0001), of advanced liver disease (p=0.0003) and a reduction of 25% of dietary intake (p 0.0001). CONCLUSIONS: One in five patients admitted to gastroenterology units could benefit from prompt nutritional intervention. Correction of nutritional status is mandatory before any surgical procedure. Emphasis on nutritional evaluation at admission and beginning of nutritional therapy where needed are particularly required in patients with advanced liver diseases, digestive neoplasms, inflammatory bowel diseases and pancreatic diseases. ABBREVIATIONS: NRS= nutritional risk score, BMI = body mass index, IBD = inflammatory bowel diseases.
Asunto(s)
Gastroenterología , Departamentos de Hospitales/estadística & datos numéricos , Desnutrición/epidemiología , Desnutrición/etiología , Adulto , Anciano , Índice de Masa Corporal , Femenino , Hospitales Universitarios/estadística & datos numéricos , Humanos , Enfermedades Inflamatorias del Intestino/complicaciones , Hepatopatías/complicaciones , Masculino , Desnutrición/diagnóstico , Desnutrición/dietoterapia , Persona de Mediana Edad , Neoplasias/complicaciones , Evaluación Nutricional , Apoyo Nutricional/métodos , Enfermedades Pancreáticas/complicaciones , Prevalencia , Estudios Prospectivos , Medición de Riesgo , Factores de Riesgo , Rumanía/epidemiología , Pérdida de PesoRESUMEN
UNLABELLED: The aim of the paper was to evaluate the national availability of colonoscopy and the quality parameters of this procedure in our country. MATERIAL AND METHOD: During a 6 months period (01.07- 31.12.2009), we performed a prospective multicenter study in which 76 centers were invited to respond to a questionnaire regarding colonoscopy, 39 centers agreeing to participate. We assessed: the number of colonoscopies, the number of total colonoscopies and the causes of incomplete colonoscopies. RESULTS: During the study period, 16,083 colonoscopies were performed, 12,294 (76.4%) of them total colonoscopies. In 1,191 cases, stenosis was the cause of incomplete colonoscopy. If we consider this an objective reason for an incomplete colonoscopy, there were 12,294 total colonoscopies (82.4%). Comparing university centers with non-university ones, the proportion of total colonoscopies was 10,400/12,475 (83.4%) vs. 1,894/2,417 (78.4%) (p less then 0.0001). However, comparing the present study with previous ones, performed in 2003 and 2007, the proportion of total colonoscopies increased from 70.5% to 76.9% and 82.4% respectively (2003 vs. 2007 p less then 0.0001; 2007 vs. 2009 p less then 0.0001), while the quality difference between university and non-university hospitals persisted. CONCLUSIONS: the quality of colonoscopy in Romania increased in the last 5 years, while the quality difference between university and non-university hospitals persisted.
Asunto(s)
Neoplasias del Colon/diagnóstico , Colonoscopía/normas , Detección Precoz del Cáncer/normas , Neoplasias del Colon/epidemiología , Colonoscopía/estadística & datos numéricos , Detección Precoz del Cáncer/estadística & datos numéricos , Hospitales Comunitarios/estadística & datos numéricos , Hospitales Universitarios/estadística & datos numéricos , Humanos , Valor Predictivo de las Pruebas , Estudios Prospectivos , Factores de Riesgo , Rumanía/epidemiología , Sensibilidad y Especificidad , Encuestas y CuestionariosRESUMEN
Coupling magnetic materials to plasmonic structures provides a pathway to dramatically increase the magneto-optical response of the resulting composite architecture. Although such optical enhancement has been demonstrated in a variety of systems, some basic aspects are scarcely known. In particular, reflectance/transmission modulations and electromagnetic field intensification, both triggered by plasmon excitations, can contribute to the magneto-optical enhancement. However, a quantitative evaluation of the impact of both factors on the magneto-optical response is lacking. To address this issue, we have measured magneto-optical Kerr spectra on corrugated gold/dielectric interfaces with magnetic (nickel and iron oxide) nanoparticles. We find that the magneto-optical activity is enhanced by up to an order of magnitude for wavelengths that are correlated to the excitation of propagating or localized surface plasmons. Our work sheds light on the fundamental principles for the observed optical response and demonstrates that the outstanding magneto-optical performance is originated by the increase of the polarization conversion efficiency, whereas the contribution of reflectance modulations is negligible.
RESUMEN
PURPOSE: Contrast-enhanced harmonic endoscopic ultrasonography (CEH-EUS) for the assessment of microcirculation and the delineation of pancreatic tumors in order to characterize and stage them has only recently become available for commercial use, and few reports have been published. The purpose of the study was the qualitative and quantitative digital image analysis of pancreatic adenocarcinomas using conventional endoscopic ultrasonography (EUS) and CEH-EUS and the evaluation of whether contrast medium injection modified adenocarcinoma staging and patient management. MATERIALS AND METHODS: In each of 30 prospectively examined patients with suspected pancreatic solid lesions, CEH-EUS was performed using the same quantity of the contrast agent SonoVue and a low mechanical index (0.3 - 0.4), followed by EUS-FNA. The histology, based on EUS-FNA or surgery and 9 months of follow-up, was: pancreatic adenocarcinoma (n = 15), pseudotumoral chronic pancreatitis (n = 12), neuroendocrine tumor (n = 1), common bile duct tumor (n = 1), lymph node metastases of gastric cancer (n = 1). The quantitative analysis was based on histograms obtained from each CEH-EUS video recording. RESULTS: CEH-EUS showed a hypoenhanced pattern in 14 cases of adenocarcinoma and in 10 cases of chronic pancreatitis. The index of the contrast uptake ratio was significantly lower in adenocarcinoma than in mass-forming chronic pancreatitis. A cut-off uptake ratio index value of 0.17 for diagnosing adenocarcinoma corresponded to an AUC (CI 95%) of 0.86 (0.67 - 1.00) with a sensitivity of 80%, a specificity of 91.7%, a positive predictive value of 92.8%, and a negative predictive value of 78%. The size of the pancreatic mass was assessed significantly more effectively by CEH-EUS but adenocarcinoma staging was not modified. CONCLUSION: The majority of cases of both pancreatic adenocarcinoma and chronic pancreatitis were hypoenhanced and visual discrimination was not possible. This is the first study about CEH-EUS for the quantitative assessment of uptake after contrast injection which has shown that it can aid differentiation between benign and malignant masses but cannot replace EUS-FNA. Neither tumor stage nor therapeutic management have changed after contrast medium injection during CEH-EUS.
Asunto(s)
Adenocarcinoma/diagnóstico por imagen , Endosonografía/métodos , Aumento de la Imagen/métodos , Procesamiento de Imagen Asistido por Computador/métodos , Neoplasias Pancreáticas/diagnóstico por imagen , Carga Tumoral/fisiología , Adenocarcinoma/irrigación sanguínea , Adenocarcinoma/patología , Anciano , Anciano de 80 o más Años , Biopsia , Medios de Contraste/administración & dosificación , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Microvasos/diagnóstico por imagen , Persona de Mediana Edad , Estadificación de Neoplasias , Neovascularización Patológica/diagnóstico por imagen , Neoplasias Pancreáticas/irrigación sanguínea , Neoplasias Pancreáticas/patología , Pancreatitis Crónica/diagnóstico por imagen , Pancreatitis Crónica/patología , Fosfolípidos , Estudios Prospectivos , Hexafluoruro de AzufreAsunto(s)
Vena Porta/anomalías , Tomografía Computarizada por Rayos X , Ultrasonografía Doppler , Malformaciones Vasculares/diagnóstico , Vena Cava Inferior/anomalías , Humanos , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/etiología , Imagen por Resonancia Magnética , Masculino , Malformaciones Vasculares/complicaciones , Adulto JovenRESUMEN
Of 28 consecutive patients over 64 years old, in whom endoscopy revealed gastro-duodenal ulcers with signs of recent hemorrhage (active bleeding, non-bleeding vessel or adherent clot), 14 were randomly assigned to receive endoscopic alcoholization of the lesions preceded by intragastric instillation of norepinephrine, while as controls 14 received antacids. After the applied treatment the bleeding stopped in all cases (100%) in the study group and one patient died (7.1%) after hemostasis was achieved. In the control group bleeding stopped in 12 patients (85.7%). Two patients continued to bleed and needed emergency surgery. Another patient had a major rebleed successfully treated by alcoholization. There were 4 deaths (28%): 2 patients died postoperatively and the other 2 from acute porphyria and bronchopneumonia respectively. The transfusion requirements after the entry into trial were significantly lower in the study group compared to controls (mean no. of blood units 0.79 vs. 1.71). No complications were seen with the treatment applied. These results suggest that endoscopic alcoholization of the lesions preceded by intragastric instillation of norepinephrine is an effective and safe emergency therapy for bleeding from peptic ulcers in old age patients.
Asunto(s)
Endoscopía , Etanol/administración & dosificación , Técnicas Hemostáticas , Norepinefrina/administración & dosificación , Úlcera Péptica Hemorrágica/terapia , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Instilación de Medicamentos , Intubación Gastrointestinal , Masculino , Úlcera Péptica Hemorrágica/diagnóstico , Ensayos Clínicos Controlados Aleatorios como Asunto , RecurrenciaRESUMEN
The incidence of the Helicobacter-like organisms (HLO) was investigated on biopsy specimens of antral gastric mucosa, stained by the Wayson technique, in 509 patients with various gastric and duodenal diseases. The incidence of HLO was: 72.8 percent in gastric ulcer, 69.6 percent in duodenal ulcer, 69.2 percent in bulbitis, 61.0. percent in chronic gastritis, 37.5 percent in the postoperative stomach, 50 percent in gastric cancer, and 34.3 percent on healthy controls. The HLO were present over the whole year, with a peak in March. Sex and age had little influence on the HLO incidence. The Wayson staining technique proved to be a good technique of detection of HLO on gastric mucosa smears.
Asunto(s)
Campylobacter/aislamiento & purificación , Enfermedades Duodenales/microbiología , Gastropatías/microbiología , Adulto , Biopsia , Enfermedad Crónica , Úlcera Duodenal/microbiología , Duodenitis/microbiología , Femenino , Mucosa Gástrica/microbiología , Gastritis/microbiología , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Gastropatías/cirugía , Neoplasias Gástricas/microbiología , Úlcera Gástrica/microbiologíaRESUMEN
OBJECTIVE: We studied the prevalence of viral hepatitis B, C and D markers in chronic hepatopathies from Cluj. MATERIAL AND METHODS: Sera of 297 patients with chronic hepatopathies (236 adults and 61 children) have been tested for viral hepatitis markers: HBsAg, anti-HBc, anti-HBs, HBeAg, anti-HBe, anti-HDV, anti-HCV, by automated ELISA. RESULTS: HBV infection markers in 32% (adults) and 4.9% (children), and HDV infection markers in 11.8% (adults) and 26.3% (children). Double (HBV and HCV) and triple infection (HBV, HDV and HCV) were observed in 28.4% (adults), 4.9% (children), and 3.4% (adults), 0% (children), respectively. CONCLUSIONS: Hepatitis virus infection markers, especially HBV and HCV play an important role in the determinism of chronic hepatopathies from Cluj area, both in children and adults.
Asunto(s)
Hepatitis B/complicaciones , Hepatitis C/complicaciones , Hepatitis D/complicaciones , Hepatopatías/etiología , Población Urbana , Adulto , Biomarcadores/sangre , Distribución de Chi-Cuadrado , Niño , Enfermedad Crónica , Anticuerpos Antihepatitis/sangre , Antígenos de la Hepatitis/sangre , Hepatitis B/epidemiología , Hepatitis C/epidemiología , Hepatitis D/epidemiología , Humanos , Hepatopatías/epidemiología , Prevalencia , Rumanía/epidemiología , Estudios Seroepidemiológicos , Población Urbana/estadística & datos numéricosRESUMEN
OBJECTIVE: We aimed to assess the seroprevalence of HBV, HCV and HDV virus markers in multi-transfused patients from Cluj-Napoca. MATERIAL AND METHODS: Stored serum samples of 105 multi-transfused patients (25 children, 19 adults and 61 chronically hemodialyzed patients) have been tested for HBsAg, anti-HBs, total anti-HBc, anti-HCV, total anti-HDV by automated ELISA (Sanofi Diagnostics Pasteur kits). RESULTS: HVC infection has been observed in 4/25 (16%) children, 14/19 (74%) multi-transfused adults and 48/61 (79%) haemodialysis patients. 8/25 (32%) children, 17/19 (89%) adults and 47/61 (77%) haemodialysis patients had HBV infection markers. Anti-HDV have not been found in HBV infected multi-transfused children and adults, respectively. Only 2/47 (4.25%) HBV infected haemodialysis patients had HDV infection markers. The prevalence of double infection (HCV and HBV) was high (4%, 84.2% and 67.2% in children, adults and haemodialysis patients). The prevalence of viral hepatitis markers correlated to the amount of transfused blood, and in haemodialysis patients also correlated to the duration on dialysis. CONCLUSIONS: In multi-transfused patients from Cluj area, the prevalence of viral hepatitis markers is high. The double infection (HCV and HBV) is frequent, especially in adults. The prevalence of HDV infection markers in HBV infected patients is low, in contrast with previously reported results.
Asunto(s)
Transfusión Sanguínea , Hepatitis A/inmunología , Hepatitis B/inmunología , Hepatitis D/inmunología , Adolescente , Adulto , Anciano , Biomarcadores/sangre , Transfusión Sanguínea/estadística & datos numéricos , Niño , Preescolar , Femenino , Hepatitis A/epidemiología , Anticuerpos Antihepatitis/sangre , Antígenos de la Hepatitis/sangre , Hepatitis B/epidemiología , Hepatitis D/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Diálisis Renal/estadística & datos numéricos , Rumanía/epidemiología , Estudios SeroepidemiológicosRESUMEN
AIM: Enterobacterial translocation into the gut mucosa is the first step required for activation of neutrophils and inducible nitric oxide synthase (iNOS), involved in the pathogenesis of indomethacin-induced intestinal lesions. Rifaximin may limit NSAID-associated intestinal damage by decreasing the bacterial load. We aimed to study the effect of rifaximin on indomethacin-induced intestinal damage in guinea-pigs. MATERIALS AND METHODS: Twenty-four guinea pigs, equally divided in four interventional groups (A-D), received indomethacin, given orally once daily (30 mg/kg) for three consecutive days. In groups B, C, D different doses of rifaximin (50 mg/kg, 100 mg/kg and 200 mg/kg) were given orally two hours before indometachin administration. Semi-quantitative grades were measure for gross findings, degenerative lesions, neutrophils and eosinophils infiltrates and iNOS immunopositivity. Statistical comparisons used Mann Whitney Test, with a Bonferroni correction for alpha (p ≤ 0.016). RESULTS: Statistical analysis of graded gross findings, microscopic degenerative lesions, endothelium damage and iNOS immunopositivity found no difference between A and B groups. Significant fewer gross findings (U = 3, p = 0.015), microscopic degenerative lesions (U = 2, p = 0.008) and lower grades for iNOS immunopositivity (U = 0, p = 0.002) were found in group C compared with group A. In group D, significant lower grades for iNOS immunopositivity were obtained (U = 0, p = 0.002) compared with group A and fewer degenerative lesions without reaching statistical significance (U = 4, p = 0.026). CONCLUSIONS: 100 mg/kg of rifaximin proved efficient in preventing gut degenerative lesions induced by indomethacin in a guinea pig model, the iNOS activity being significantly decreased.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Enteritis/tratamiento farmacológico , Fármacos Gastrointestinales/uso terapéutico , Indometacina/efectos adversos , Rifamicinas/uso terapéutico , Animales , Enteritis/enzimología , Enteritis/microbiología , Enteritis/patología , Femenino , Fármacos Gastrointestinales/administración & dosificación , Cobayas , Inmunohistoquímica , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/enzimología , Mucosa Intestinal/patología , Infiltración Neutrófila/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Rifamicinas/administración & dosificación , RifaximinaAsunto(s)
Debilidad Muscular/inducido químicamente , Debilidad Muscular/diagnóstico , Astenia/inducido químicamente , Astenia/diagnóstico , Astenia/etiología , Colchicina/efectos adversos , Diagnóstico Diferencial , Rechazo de Injerto/complicaciones , Rechazo de Injerto/diagnóstico , Rechazo de Injerto/tratamiento farmacológico , Humanos , Trasplante de Riñón/efectos adversos , Masculino , Persona de Mediana Edad , Debilidad Muscular/etiologíaRESUMEN
UNLABELLED: There are over 5000 patients with genotype 1b HCV chronic infection in Romania on national waiting lists. This allowed us to evaluate the complete and partial early virological response rates (EVRc and EVRp), as well as the factors influencing the response rates to treatment. PATIENTS: We studied 1220 treatment naive patients with HCV chronic hepatitis who started antiviral therapy during 2009. Mean age was 48 years and female gender was predominant (58%). Chronic hepatitis was documented by liver biopsy in 1129 patients (93%) or by non-invasive tests in 91 cases (7%). Most patients presented advanced liver disease (F3 + F4 Metavir = 62.3%). Viral load was over 400000 iu/mL in 61% patients and over 600000 iu/mL in 52% patients. Treatment was performed with peginterferon alpha-2a in 75.2% patients and with peginterferon alpha-2b in 24.8% patients, with comparative histology. The influence of histology, viral load, gender, age and type of peginterferon on the response rates to treatment was evaluated. RESULTS: EVRc was obtained in 76.6% patients, while 16.2% presented EVRp. From those with EVRp, 78.8% had undetectable viral load after 6 months of therapy. The nonresponder rate was 9.6%. EVRc was influenced by viral load and age, but not by fibrosis stage or type of interferon. CONCLUSIONS: We noticed a high rate of EVRc, which was not influenced by histology, gender or type of interferon. The number of nonresponders and of patients who interrupted therapy due to lack of compliance or adverse events was low.
Asunto(s)
Antivirales/uso terapéutico , Hepacivirus/efectos de los fármacos , Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Cirrosis Hepática/tratamiento farmacológico , Polietilenglicoles/uso terapéutico , Ribavirina/uso terapéutico , Carga Viral/efectos de los fármacos , Adulto , Biopsia , Progresión de la Enfermedad , Quimioterapia Combinada , Femenino , Genotipo , Hepatitis C Crónica/epidemiología , Hepatitis C Crónica/genética , Hepatitis C Crónica/patología , Humanos , Interferón alfa-2 , Cirrosis Hepática/epidemiología , Cirrosis Hepática/genética , Cirrosis Hepática/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Proteínas Recombinantes/uso terapéutico , Ribavirina/administración & dosificación , Medición de Riesgo , Factores de Riesgo , Rumanía/epidemiología , Factores de Tiempo , Insuficiencia del Tratamiento , Resultado del TratamientoAsunto(s)
Niño Institucionalizado/estadística & datos numéricos , Hepatitis B/epidemiología , Portador Sano/epidemiología , Portador Sano/inmunología , Niño , Preescolar , Hepatitis B/inmunología , Antígenos de Superficie de la Hepatitis B/sangre , Humanos , Lactante , Prevalencia , Rumanía/epidemiología , Estudios SeroepidemiológicosRESUMEN
UNLABELLED: The Helicobacter pylori (Hp) infection is a well-known carcinogenic factor. There are only limited data on the presence of Hp infection in gastric cancer in Romania. AIM: Cross-sectional study of the prevalence of Hp infection in gastric cancer. MATERIAL-METHODS: All cases of gastric cancer confirmed by gastroscopy in an endoscopy unit with national referrals were analysed. The Hp status was checked. The Hp + cases were studied compared with the Hp - cases. RESULTS: From 6768 gastroscopies 84 cases with gastric cancer were detected. Among these in 40 the Hp status was determined. 37 cases were carcinoma, 1 lymphoma, 2 cases without microscopical aspect of malignancy. In 8 cases (20%) Hp was found +. The majority of the patients with gastric cancer did not use PPIs. There were no demographic life style differences between the patients with gastric cancer who were Hp + and Hp -. CONCLUSION: Prevalence of the Hp infection in gastric cancer is lower than that reported in the literature. The investigation of Hp in gastric cancer should be done routinely. These data represent the starting point for a prospective study.
Asunto(s)
Infecciones por Helicobacter/epidemiología , Helicobacter pylori , Neoplasias Gástricas/epidemiología , Neoplasias Gástricas/microbiología , Anciano , Comorbilidad , Estudios Transversales , Femenino , Gastroscopía , Humanos , Masculino , Persona de Mediana Edad , PrevalenciaRESUMEN
BACKGROUND/AIMS: Sedation rates may vary among countries, depending on patients' and endoscopists' preferences. The aim of this survey was to investigate the rate of using premedication for routine diagnostic upper gastrointestinal (UGI) endoscopy in endoscopy societies, members of the European Society of Gastrointestinal Endoscopy (ESGE). METHODS: We evaluated a multiple-choice questionnaire which was e-mailed to representatives of national endoscopy societies, which are members of the ESGE. The questionnaire had 14 items referring to endoscopy practices in each country and the representatives' endoscopy units. RESULTS: The response rate was 76% (34/45). In 47% of the countries, less than 25% of patients undergo routine diagnostic UGI endoscopy with conscious sedation. In 62% of the responders' endoscopy units, patients are not asked their preference for sedation and do not sign a consent form (59%). Common sedatives in use are midazolam (82%), diazepam (38%) or propofol (47%). Monitoring equipment is not available 'in most of the endoscopy units' in 46% (13/28) of the countries. Though they were available in 91% of the national representatives' endoscopy units, they are rarely (21%) used to monitor unsedated routine diagnostic UGI endoscopy. CONCLUSIONS: In about 50% of ESGE-related countries, less than 25% of patients are sedated for routine diagnostic UGI endoscopy. Major issues to improve include availability of monitoring equipment and the use of a consent form.
Asunto(s)
Sedación Consciente/estadística & datos numéricos , Endoscopía Gastrointestinal , Enfermedades Gastrointestinales/diagnóstico , Femenino , Encuestas de Atención de la Salud , Humanos , Hipnóticos y Sedantes/administración & dosificación , Masculino , Sociedades Médicas , Encuestas y CuestionariosRESUMEN
Starting from the hypothesis that duodenal ulcer pain is induced by oxygen free radicals, a process demonstrated in other types of bacterial or nonbacterial inflammations, we used a powerful scavenger of human origin in local periulcerous injections performed through endoscope in 12 patients with duodenal ulcer and active lasting pain. Pain subsided in all patients for a variable period of time. The results obtained plead for the involvement of oxygen free radicals in the mechanism of ulcer pain.
Asunto(s)
Catalasa/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Superóxido Dismutasa/uso terapéutico , Adulto , Combinación de Medicamentos/uso terapéutico , Femenino , Radicales Libres , Humanos , Masculino , Dolor/etiologíaRESUMEN
Disodium edetate (ethylenediaminetetraacetic acid, disodium salt; disodic EDTA), 3 g, was given, via an intravenous normal saline drip of 30 min, to 25 patients in order to assess a benefit for anaesthesia practice. A significant reduction of both volume and acidity of the gastric secretion was found in all the 10 patients with peptic ulcer having received the drug. The peak of the change was 1 h after administration. In other 10 non-ulcer patients undergoing orthopaedic surgeries under epidural anaesthesia with lidocaine 2%, 5 mg kg-1, pH of the gastric juice unanimously rose, from 2.24 +/- 0.28 to 4.10 +/- 0.21 1 h after EDTA with a P derived from paired difference analysis of less than 0.001. A similar group of patients receiving only normal saline showed no important changes in pH (from 2.37 +/- 0.24 to 2.34 +/- 0.19). The pH of the fundic surface, measured directly under fiberscopic control in further 5 patients suffering from peptic ulcer, was found also to rise from 1.84 +/- 0.21 to 4.62 +/- 0.34 1 h after EDTA, P less than 0.001. Total and ionized calcium changed unsignificantly. Disodic EDTA in the dose and manner used in this study showed no clinical side-effects. The constant and obvious effect of inhibition of the gastric secretion as well as the dynamics of such an action recommend disodic EDTA to be tried in reducing the aspiration pneumonia morbidity.